Drug comparisons
Erenumab vs Lasmiditan
Erenumab (Aimovig) is a preventive CGRP monoclonal antibody, Lasmiditan (Reyvow) is an acute 5-HT1F agonist for migraines. Compare mechanisms, efficacy, and use cases.
No comparison dimensions are available for this page.
Clinical context
Patients looking to switch from one migraine medication to another or comparing preventive options often search for Erenumab vs Lasmiditan.
Bottom line
Both Erenumab and Lasmiditan are valuable migraine treatments but are used for different purposes.
All medication comparisons